Literature DB >> 26108730

Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.

Ellen Neven1, Rida Bashir-Dar1, Geert Dams1, Geert J Behets1, Anja Verhulst1, Monique Elseviers2, Patrick C D'Haese1.   

Abstract

Because current rat models used to study chronic kidney disease (CKD)-related vascular calcification show consistent but excessive vascular calcification and chaotic, immeasurable, bone mineralization due to excessive bone turnover, they are not suited to study the bone-vascular axis in one and the same animal. Because vascular calcification and bone mineralization are closely related to each other, an animal model in which both pathologies can be studied concomitantly is highly needed. CKD-related vascular calcification in rats was induced by a 0.25% adenine/low vitamin K diet. To follow vascular calcification and bone pathology over time, rats were killed at weeks 4, 8, 10, 11, and 12. Both static and dynamic bone parameters were measured. Vascular calcification was quantified by histomorphometry and measurement of the arterial calcium content. Stable, severe CKD was induced along with hyperphosphatemia, hypocalcemia as well as increased serum PTH and FGF23. Calcification in the aorta and peripheral arteries was present from week 8 of CKD onward. Four and 8 weeks after CKD, static and dynamic bone parameters were measurable in all animals, thereby presenting typical features of hyperparathyroid bone disease. Multiple regression analysis showed that the eroded perimeter and mineral apposition rate in the bone were strong predictors for aortic calcification. This rat model presents a stable CKD, moderate vascular calcification, and quantifiable bone pathology after 8 weeks of CKD and is the first model that lends itself to study these main complications simultaneously in CKD in mechanistic and intervention studies.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE DISEASE; CHRONIC KIDNEY DISEASE; MINERAL ABNORMALITIES; RAT MODEL; VASCULAR CALCIFICATION

Mesh:

Substances:

Year:  2015        PMID: 26108730     DOI: 10.1002/jbmr.2585

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Characterization of an Animal Model to Study Risk Factors and New Therapies for the Cardiorenal Syndrome, a Major Health Issue in Our Aging Population.

Authors:  Anja Verhulst; Ellen Neven; Patrick C D'Haese
Journal:  Cardiorenal Med       Date:  2017-05-24       Impact factor: 2.041

2.  PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet.

Authors:  Shunsuke Yamada; Elizabeth M Leaf; Jia Jun Chia; Timothy C Cox; Mei Y Speer; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2018-07-21       Impact factor: 10.612

3.  Pharmacological TNAP inhibition efficiently inhibits arterial media calcification in a warfarin rat model but deserves careful consideration of potential physiological bone formation/mineralization impairment.

Authors:  Britt Opdebeeck; Ellen Neven; José Luis Millán; Anthony B Pinkerton; Patrick C D'Haese; Anja Verhulst
Journal:  Bone       Date:  2020-04-30       Impact factor: 4.398

4.  Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.

Authors:  Antonia E Schantl; Anja Verhulst; Ellen Neven; Geert J Behets; Patrick C D'Haese; Marc Maillard; David Mordasini; Olivier Phan; Michel Burnier; Dany Spaggiari; Laurent A Decosterd; Mark G MacAskill; Carlos J Alcaide-Corral; Adriana A S Tavares; David E Newby; Victoria C Beindl; Roberto Maj; Anne Labarre; Chrismita Hegde; Bastien Castagner; Mattias E Ivarsson; Jean-Christophe Leroux
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

Review 5.  Mitochondrial Dysfunction: Cause or Consequence of Vascular Calcification?

Authors:  Kanchan Phadwal; Christina Vrahnas; Ian G Ganley; Vicky E MacRae
Journal:  Front Cell Dev Biol       Date:  2021-03-16

6.  Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification.

Authors:  Miguel D Ferrer; Markus Ketteler; Fernando Tur; Eva Tur; Bernat Isern; Carolina Salcedo; Pieter H Joubert; Geert J Behets; Ellen Neven; Patrick C D'Haese; Joan Perelló
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

7.  Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.

Authors:  Ellen Neven; Raphaëlle Corremans; Benjamin A Vervaet; Felix Funk; Sebastian Walpen; Geert J Behets; Patrick C D'Haese; Anja Verhulst
Journal:  Nephrol Dial Transplant       Date:  2020-10-01       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.